Polyethylene glycol 3350 and Hair loss - a phase IV clinical study of FDA data
Hair loss is found among people who take Polyethylene glycol 3350, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Polyethylene glycol 3350 and have Hair loss. It is created by eHealthMe based on reports of 1,512 people who have side effects when taking Polyethylene glycol 3350 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,512 people reported to have side effects when taking Polyethylene glycol 3350.
Among them, 8 people (0.53%) have Hair loss.
What is Polyethylene glycol 3350?
Polyethylene glycol 3350 has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 1,634 Polyethylene glycol 3350 users for its effectiveness, alternative drugs and more.
What is Hair loss?
Hair loss is found to be associated with 3,703 drugs and 3,258 conditions by eHealthMe.
Number of Polyethylene glycol 3350 and Hair loss reports submitted per year:
Time on Polyethylene glycol 3350 when people have Hair loss *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hair loss when taking Polyethylene glycol 3350 *:
- female: 87.5 %
- male: 12.5 %
Age of people who have Hair loss when taking Polyethylene glycol 3350 *:
- 0-1: 0.0 %
- 2-9: 12.5 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25.0 %
- 60+: 62.5 %
Common drugs people take besides Polyethylene glycol 3350 *:
- Nexium: 3 people, 37.50%
- Lorazepam: 3 people, 37.50%
- Hydrochlorothiazide: 2 people, 25.00%
- Xenical: 2 people, 25.00%
- Furosemide: 2 people, 25.00%
- Famotidine: 2 people, 25.00%
- Effexor Xr: 2 people, 25.00%
- Diflucan: 2 people, 25.00%
- Cozaar: 2 people, 25.00%
- Claritin: 2 people, 25.00%
Common side effects people have besides Hair loss *:
- High Blood Pressure: 3 people, 37.50%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 25.00%
- Malaise (a feeling of general discomfort or uneasiness): 2 people, 25.00%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 25.00%
- Dysphemia (stammering or stuttering): 2 people, 25.00%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 25.00%
- Mitral Valve Prolapse (heart's mitral valve doesn't work well): 2 people, 25.00%
- Mitral Valve Incompetence (inefficient heart valve): 2 people, 25.00%
- Marital Problem: 2 people, 25.00%
- Lymphoedema (localized fluid retention and tissue swelling): 2 people, 25.00%
Common conditions people have *:
- Menopausal Symptoms: 2 people, 25.00%
- High Blood Cholesterol: 2 people, 25.00%
- Menopause (end of monthly cycles in women): 1 person, 12.50%
- High Blood Pressure: 1 person, 12.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 12.50%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 12.50%
- Diabetes: 1 person, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Polyethylene glycol 3350 and have Hair loss?Check whether Hair loss is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
How severe was Hair loss and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Alternative drugs to, pros and cons of Polyethylene glycol 3350:
- Polyethylene glycol 3350 (1,634 reports)
Common Polyethylene glycol 3350 side effects:
- Drug ineffective: 198 reports
- Indigestion: 151 reports
- Constipation: 124 reports
- Abdominal pain: 120 reports
- Stress and anxiety: 118 reports
- Diarrhea: 108 reports
Browse all side effects of Polyethylene glycol 3350:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hair loss treatments and more:
- Hair loss (238,472 reports)
COVID vaccines that are related to Hair loss:
- Hair loss in Moderna COVID Vaccine
- Hair loss in Pfizer BioNTech Covid Vaccine
- Hair loss in Johnson and Johnson Covid Vaccine
Common drugs associated with Hair loss:
- Taxotere: 34,064 reports
- Docetaxel: 25,062 reports
- Methotrexate: 16,710 reports
- Humira: 14,833 reports
- Enbrel: 14,300 reports
- Prednisone: 13,908 reports
- Neosar: 11,976 reports
- Remicade: 10,226 reports
- Orencia: 9,671 reports
- Arava: 8,730 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,703 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 18,564 reports
- Multiple sclerosis: 13,366 reports
- Breast cancer: 11,002 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,258 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Polyethylene glycol 3350) and Polyethylene glycol 3350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rasilez and Dengue Fever - now
- Concerta and Diarrhea Aggravated - 2 seconds ago
- Sumatriptan and Glucose Urine Present - 13 seconds ago
- Roxicodone and Lyme Disease - 15 seconds ago
- Paxil and Zide drug interaction - 17 seconds ago
- Nebivolol Hydrochloride and Sevelamer Hydrochloride drug interaction - 23 seconds ago
- Sumatriptan Succinate and Multi-Organ Failure - 26 seconds ago
- How effective is Ritalin for Sleep Disorder? - 28 seconds ago
- Bystolic vs. Plendil - 28 seconds ago
- Cosopt and Scopolamine drug interaction - 28 seconds ago